Meta-signature of mutated genes in gallbladder cancer: Evidence based high throughput screening assays

Kai Qu; Xing Zhang; Ruixia Cui; Chang Liu

doi:10.21037/atm.2016.05.57

Meta-signature of mutated genes in gallbladder cancer: Evidence based high throughput screening assays

Kai Qu
, Xing Zhang
, Ruixia Cui
, Chang Liu

The First Affiliated Hospital of Xi’an Jiaotong University

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Original language	English
Article number	229
Journal	Annals of Translational Medicine
Volume	4
Issue number	11
DOIs	https://doi.org/10.21037/atm.2016.05.57
State	Published - Jun 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/atm.2016.05.57

Cite this

@article{da065b0ccffc4b2d89c7e9728efc6e53,

title = "Meta-signature of mutated genes in gallbladder cancer: Evidence based high throughput screening assays",

author = "Kai Qu and Xing Zhang and Ruixia Cui and Chang Liu",

year = "2016",

month = jun,

doi = "10.21037/atm.2016.05.57",

language = "英语",

volume = "4",

journal = "Annals of Translational Medicine",

issn = "2305-5839",

publisher = "AME Publishing Company",

number = "11",

}

TY - JOUR

T1 - Meta-signature of mutated genes in gallbladder cancer

T2 - Evidence based high throughput screening assays

AU - Qu, Kai

AU - Zhang, Xing

AU - Cui, Ruixia

AU - Liu, Chang

PY - 2016/6

Y1 - 2016/6

UR - https://www.scopus.com/pages/publications/85006210867

U2 - 10.21037/atm.2016.05.57

DO - 10.21037/atm.2016.05.57

M3 - 评论/辩论

AN - SCOPUS:85006210867

SN - 2305-5839

VL - 4

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

IS - 11

M1 - 229

ER -

Meta-signature of mutated genes in gallbladder cancer: Evidence based high throughput screening assays

UN SDGs

Access to Document

Other files and links

Cite this